The results suggest that the TGF-β and Hif-1α pathways may play synergetic roles in myocardial fibrosis, and the cardiac protection by valsartan after MI was through inhibiting both TGF-β and Hif-1α. This evidence concerns the gene TGFB1 and Myocardial fibrosis.